Getting medicine into the brain is one of the biggest challenges in treating Alzheimer’s disease. With a $3.1 million NIH grant, U-M researchers are exploring a new way to deliver genetic treatments to the brain through a standard IV.
Getting medicine into the brain is one of the biggest challenges in treating Alzheimer’s disease. With a $3.1 million NIH grant, U-M researchers are exploring a new way to deliver genetic treatments to the brain through a standard IV.